How Old is Too Old to Operate for Mesothelioma? Justin M. Karush Thoracic Oncology 10 May 2019 Pages: 2311 - 2312
Does a Lymph Node-Based Model Predict Clinical Value for Adjuvant Therapy in Squamous Cell Carcinoma of the Esophagus Treated With Upfront Surgery? Dana McCloskeyDavid D. Shersher Thoracic Oncology 11 June 2019 Pages: 2313 - 2315
Sentinel Node Biopsy After Neoadjuvant Systemic Therapy for Breast Cancer: The Method Matters Harry D. BearKandace P. McGuire Breast Oncology 24 April 2019 Pages: 2316 - 2318
Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence, Technically Feasible but Influence on Oncologic Outcomes Yet to be Completely Defined James W. Jakub Breast Oncology 29 April 2019 Pages: 2319 - 2321
Let’s Not Forget About Regional Therapy for the Treatment of Locally Advanced Extremity Melanoma Giorgos C. Karakousis Melanoma 06 May 2019 Pages: 2322 - 2324
Resolve the Conflict Rather than Dissolve the Relationship Sandra L. WongSteven C. Stain Health Services Research and Global Oncology 03 June 2019 Pages: 2325 - 2326
Changing Trends in Industry Funding for Surgical Oncologists Juan A. Santamaria-BarriaStacey SternAnton Bilchik Health Services Research and Global Oncology 29 April 2019 Pages: 2327 - 2335
Palliative Care and Symptom Burden in the Last Year of Life: A Population-Based Study of Patients with Gastrointestinal Cancer Shaila J. MerchantSusan B. BroglyNancy N. Baxter Health Services Research and Global Oncology 09 April 2019 Pages: 2336 - 2345
ASO Author Reflections: Managing Symptoms at the End-of-Life—Some Progress, Many Unanswered Questions Shaila J. Merchant ASO Author Reflections 29 May 2019 Pages: 2346 - 2347
Contemporary Improvements in Postoperative Mortality After Major Cancer Surgery are Associated with Weakening of the Volume-Outcome Association Nabil WasifDavid EtzioniYu-Hui Chang Health Services Research and Global Oncology 07 May 2019 Pages: 2348 - 2356
Management of Malignant Pleural Mesothelioma in the Elderly Population Vivek VermaRodney E. WegnerCharles B. Simone II Thoracic Oncology 22 April 2019 Pages: 2357 - 2366
Predicting the Value of Adjuvant Therapy in Esophageal Squamous Cell Carcinoma by Combining the Total Number of Examined Lymph Nodes with the Positive Lymph Node Ratio Yida LiWeixin ZhaoZhengfei Zhu Thoracic Oncology 11 June 2019 Pages: 2367 - 2374
The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma Sander J. M. van HootegemB. Mark SmithersAndrew P. Barbour Thoracic Oncology Open access 02 April 2019 Pages: 2375 - 2384
Predicting the Risk of Weight Loss After Esophageal Cancer Surgery Anna SchandlJoonas H. KauppilaPernilla Lagergren Thoracic Oncology Open access 19 April 2019 Pages: 2385 - 2391
Adjuvant Chemotherapy Candidates in Stage I Lung Adenocarcinomas Following Complete Lobectomy Jie QianJianlin XuBaohui Han Thoracic Oncology 22 April 2019 Pages: 2392 - 2400
Tumor Volume Is Better Than Diameter for Predicting the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer Hao-jun XieXu ZhangXiao-dong Su Thoracic Oncology 03 May 2019 Pages: 2401 - 2408
The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial So-Youn JungJai Hong HanSeeyoun Lee Breast Oncology 07 May 2019 Pages: 2409 - 2416
Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence Ingrid G. M. PoodtCoco J. E. F. Walstrathe Sentinel Node And Recurrent Breast Cancer (SNARB) study group Breast Oncology 08 March 2019 Pages: 2417 - 2427
Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence Masataka SawakiTakeshi MiyamotoHiroji Iwata Breast Oncology 16 April 2019 Pages: 2428 - 2434
Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study André HennigsFabian RiedelJörg Heil Breast Oncology 02 May 2019 Pages: 2435 - 2443
Psychosocial Functioning in Women with Early Breast Cancer Treated with Breast Surgery With or Without Immediate Breast Reconstruction Helene RetrouveyIsabel KerrebijnToni Zhong Breast Oncology 06 May 2019 Pages: 2444 - 2451
Pretreatment Tattoo Marking of Suspicious Axillary Lymph Nodes: Reliability and Correlation with Sentinel Lymph Node Rupa PatelWendy MacKerricherIrene L. Wapnir Breast Oncology 13 May 2019 Pages: 2452 - 2458
Oncoplastic Level 2 Mammoplasty for Large DCIS: 5-Year Results R. F. D. van la ParraK. B. CloughC. Nos Breast Oncology 13 May 2019 Pages: 2459 - 2465
Single-Incision Approach for Breast-Conserving Surgery: Effectiveness, Complications and Quality of Life Benigno Acea-NebrilAlejandra García-NovoaJoaquín Mosquera-Oses Breast Oncology 17 May 2019 Pages: 2466 - 2474
Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry Minoru MiyashitaNaoki NiikuraYutaka Tokuda Breast Oncology 17 May 2019 Pages: 2475 - 2485
Long–Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis John T. MiuraHidde M. KroonJonathan S. Zager Melanoma 25 March 2019 Pages: 2486 - 2494
ASO Author Reflections: International Experience of Isolated Limb Infusion for Melanoma Shows Durable Response John T. MiuraHidde M. KroonJonathan S. Zager ASO Author Reflections 13 May 2019 Pages: 2495 - 2496
For Patients with Early Rectal Cancer, Does Local Excision Have an Impact on Recurrence, Survival, and Quality of Life Relative to Radical Resection? Amy L. HalversonArden M. MorrisGeorge J. Chang Colorectal Cancer 25 April 2019 Pages: 2497 - 2506
Phase II Trial of Neoadjuvant Chemotherapy, Chemoradiotherapy, and Laparoscopic Surgery with Selective Lateral Node Dissection for Poor-Risk Low Rectal Cancer Tsuyoshi KonishiEiji ShinozakiKensei Yamaguchi Colorectal Cancer 08 April 2019 Pages: 2507 - 2513
The Pelvis-First Approach for Robotic Proctectomy in Patients with Redundant Abdominal Colon Yun YangSongphol MalakornY. Nancy You Colorectal Cancer 17 May 2019 Pages: 2514 - 2515
Laparoscopic Complete Mesocolic Excision for Double Flexural Colon Cancers Takeru MatsudaHiroshi HasegawaYoshihiro Kakeji COLORECTAL CANCER 29 March 2019 Pages: 2516 - 2516
Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group Alexandra G. Lopez-AguiarMohammad Y. ZaidiShishir K. Maithel Endocrine Tumors 19 April 2019 Pages: 2517 - 2524
The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors Aaron T. ScottDaniel PelletierJames R. Howe Endocrine Tumors 22 April 2019 Pages: 2525 - 2532
Papillary Thyroid Cancers with Focal Tall Cell Change are as Aggressive as Tall Cell Variants and Should Not be Considered as Low-Risk Disease Pim J. BongersWouter P. KluijfhoutJesse D. Pasternak Endocrine Tumors 21 May 2019 Pages: 2533 - 2539
Para-aortic Lymphadenectomy for Gynecologic Cancers: Introducing the “Trans-Retro-Peritoneal (TRP) Single-Port Access” Loïc LelievrePatrice Mathevet Gynecologic Oncology Open access 23 April 2019 Pages: 2540 - 2541
Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy Janice L. FarlowAndrew C. BirkelandMatthew E. Spector Head and Neck Oncology 04 March 2019 Pages: 2542 - 2548
Recurrence Patterns and Timing Courses Following Curative-Intent Resection for Intrahepatic Cholangiocarcinoma Liang-Shuo HuXu-Feng ZhangTimothy M. Pawlik Hepatobiliary Tumors 24 April 2019 Pages: 2549 - 2557
ASO Author Reflections: Understanding Recurrence Patterns and Time Courses of Intrahepatic Cholangiocarcinoma After Surgery Helps in Postoperative Surveillance and Treatment Timothy M. Pawlik ASO Author Reflections 10 May 2019 Pages: 2558 - 2559
Predictors and Cumulative Frequency of Hepatocellular Carcinoma in High and Intermediate LI-RADS Lesions: A Cohort Study from a Canadian Academic Institution Ephraim Shin-Tian TangGrayson HallSulaiman Nanji Hepatobiliary Tumors 25 April 2019 Pages: 2560 - 2567
Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma Hidetoshi NittaMarc-Antoine AllardRené Adam Hepatobiliary Tumors 03 May 2019 Pages: 2568 - 2576
Full Laparoscopic Anatomical Segment 8 Resection for Hepatocellular Carcinoma Using the Glissonian Approach with Indocyanine Green Dye Fluorescence Giammauro BerardiGo WakabayashiKou Nishikawa Hepatobiliary Tumors 07 May 2019 Pages: 2577 - 2578
Intraoperative Air Leak Test to Prevent Bile Leak After Right Posterior Sectionectomy with En Bloc Diaphragm Resection for Metastatic Teratoma Timothy J. VreelandEve Beaudry SimoneauChing-Wei D. Tzeng Hepatobiliary Tumors 07 May 2019 Pages: 2579 - 2579
Clinical Importance of Sputum in the Respiratory Tract as a Predictive Marker of Postoperative Morbidity After Esophagectomy for Esophageal Cancer Naoya YoshidaAtsushi MoritoHideo Baba Gastrointestinal Oncology 29 May 2019 Pages: 2580 - 2586
Proton Radiotherapy for Isolated Local Recurrence of Primary Resected Pancreatic Ductal Adenocarcinoma Takuya MizumotoKazuki TerashimaTakumi Fukumoto Pancreatic Tumors 30 May 2019 Pages: 2587 - 2594
RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score A. Arjona-SanchezL. Rodriguez-OrtizJ. Briceño Peritoneal Surface Malignancy 20 May 2019 Pages: 2595 - 2604
ASO Author Reflections: Tending Towards a Personalized Medicine for Colorectal Carcinomatosis by Adding the RAS Mutation Status in the Workup for CRS and HIPEC A. Arjona-SanchezLidia Rodriguez-Ortiz ASO Author Reflections 19 April 2019 Pages: 2605 - 2606
Discordant Diagnostic Terminology and Pathologic Grading of Primary Appendiceal Mucinous Neoplasms Reviewed at a High-Volume Center Haroon A. ChoudryReetesh K. PaiDavid L. Bartlett Peritoneal Surface Malignancy 20 May 2019 Pages: 2607 - 2614
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP) Israel ManzanedoFernando PereiraJosé Gil Martínez Peritoneal Surface Malignancy 21 May 2019 Pages: 2615 - 2621
Preoperative Nutrition Status and Postoperative Outcomes in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Lauren ReeceHelen DragicevichDavid L. Morris Peritoneal Surface Malignancy 23 May 2019 Pages: 2622 - 2630
A Combination of Positive Tumor HLA-I and Negative PD-L1 Expression Provides an Immune Rejection Mechanism in Bladder Cancer José Francisco Flores-MartínFrancisco PereaNatalia Aptsiauri Translational Research and Biomarkers 22 April 2019 Pages: 2631 - 2639